Rivoglitazone 185428-18-6
Rivoglitazone is a thiazolidinedione undergoing research for use in the treatment of type 2 diabetes. It is being developed by Daiichi Sankyo Co.
read more [+]| Systematic (IUPAC) name: | (RS)-5-{4-[(6-methoxy-1-methyl-1H-benzimidazol-2-yl) methoxy]benzyl}-1,3-thiazolidine-2,4-dione |
|---|---|
| Rivoglitazone CAS number: | 185428-18-6 |
| ATC code: | |
| PubChem: | 3055168 |
| DrugBank: | |
| Formula: | C20H19N3O4 |
| Molecular mass: | 397.448 g/mol |
| Rivoglitazone Assay/Purity: | Typically NLT 98% |
